Nawaf Alanazi et al. 2022. INVESTIGATIONS ON CLINICAL VALIDATION OF MUTATED ZNF208 AS A NOVEL BIOMARKER OF BLAST CRISIS IN CHRONIC MYELOID LEUKEMIA. Journal of Population Therapeutics and Clinical Pharmacology. 29, 01 (Jan. 2022), 476–492. DOI:https://doi.org/10.53555/68zhqm37.